CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

CYBERDYNE Inc.

German Bionic is a leading provider of robotic exoskeleton solutions designed to enhance human performance in industrial settings. The company's products aim to increase the safety and efficiency of workers by providing ergonomic support that reduces physical strain and the risk of injury.

Dirk Poeschl

Armin Schmidt

German Bionic

CYBERDYNE develops and offers robotic technologies, particularly focused on medical and non-medical applications using HAL® robotic suits for rehabilitation and assistance. The company provides both products and related services.

Metric
Company Name	CYBERDYNE Inc.	German Bionic
Symbol	7.78K
MSH ID	JP:CYBERDYNE	COM:GERMANBIONIC
Market	STOCKS	PRIVATE
Sector	Healthcare	Technology
Industry	Medical - Devices	Robotics and Exoskeleton Technology
Country	JP	DE
Stage		Series A
Employee Count	227	77
Website	cyberdyne.jp	germanbionic.com
LinkedIn		germanbionic
Founders

Metric
Market Cap	193.79M
Enterprise Value
Monthly Web Traffic		1.25K
Web Traffic Growth		0.24
Valuation
Raised Capital		16.15M

Metric
Revenue	29.51M
Revenue (LTM)
Revenue (NTM)
Gross Profit	16.22M
EBITDA	-7.18M
Operating Income	-11.77M
Net Income	-10.01M
EPS	-0.05
Diluted EPS	-0.05
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.47
Operating Profit Margin	-0.50
EBITDA Margin	-0.24
Net Profit Margin	-0.32
Return on Equity	-0.03
Return on Assets	-0.03
Return on Capital Employed	-0.04

JP:CYBERDYNE

CYBERDYNE

Last Close

174.00

02/05 06:30

Market Cap

28.59B

Beta: -

Volume Today

578.10K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-37.75
P/B Ratio	1.06
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	7.45
EV Multiple	-16.77

Metric
Days Sales Outstanding	58.70
Days Payables Outstanding	97.14
Days Inventory Outstanding	174.20
Operating Cycle	220.83
Cash Conversion Cycle	140.64
Asset Turnover	0.09

Metric
Operating Cash Flow	-5.76M
Free Cash Flow	-7.28M
Cash Flow to Debt	-1.45
Operating Cash Flow/Sales	-0.09
Free Cash Flow Yield	-0.04

Metric
Cash & Equivalents	34.94M
Accounts Receivable	-908.33K
Inventory	6.76M
Goodwill	14.47M
Debt to Capitalization	0.01
Debt to Assets	0.01
Current Ratio	17.11
Quick Ratio	17.20

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.20
SG&A to Revenue	0.72